Real-life Assessment of BioFire FilmArray Pneumonia Panel in Adults Hospitalized With Respiratory Illness
- PMID: 37369370
- PMCID: PMC10786250
- DOI: 10.1093/infdis/jiad221
Real-life Assessment of BioFire FilmArray Pneumonia Panel in Adults Hospitalized With Respiratory Illness
Abstract
Background: Inability to identify the microbial etiology of lower respiratory tract infection leads to unnecessary antibiotic use. We evaluated the utility of the BioFire FilmArray Pneumonia Panel (BioFire PN) to inform microbiologic diagnosis.
Methods: Hospitalized adults with respiratory illness were recruited; sputa and clinical/laboratory data were collected. Sputa were cultured for bacteria and tested with BioFire PN. Microbial etiology was adjudicated by 4 physicians. Bacterial polymerase chain reaction (PCR) was compared with culture and clinical adjudication.
Results: Of 298 sputa tested, BioFire PN detected significantly more pathogens (350 bacteria, 16 atypicals, and 164 viruses) than sputum culture plus any standard-of-care testing (91% vs 60%, P < .0001). When compared with culture, the sensitivity of BioFire PN for individual bacteria was 46% to 100%; specificity, 61% to 100%; and negative predictive value, 92% to 100%. Cases were adjudicated as viral (n = 58) and bacterial (n = 100). PCR detected bacteria in 55% of viral cases and 95% of bacterial (P < .0001). High serum procalcitonin and bacterial adjudication were more often associated with sputa with 106 or 107 copies detected.
Conclusions: Multiplex PCR testing of sputa for bacteria is useful to rule out bacterial infection with added value to detect viruses and atypical bacteria.
Keywords: bacteria; diagnostic; respiratory illness; sputum; viruses.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest . None of the authors have any financial conflicts with the data presented in this article. A. R. F. receives research funding from Janssen, Merck, Pfizer, CyanVac, Vaccine Company, and BioFire Diagnostics; consulting fees from Sanofi Pasteur and Arrow Pharmaceuticals; and fees for DMSB service for Novavax. A. R. B. receives research funding from Merck, Pfizer, CyanVac, and Vaccine Company and consulting fees from Jansen and GSK. E. E. W. receives research funding from Merck, Vaccine Company, and Pfizer and consulting fees for Merck. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures
Similar articles
-
Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units.J Microbiol Immunol Infect. 2019 Dec;52(6):920-928. doi: 10.1016/j.jmii.2019.10.009. Epub 2019 Nov 23. J Microbiol Immunol Infect. 2019. PMID: 31806539 Free PMC article.
-
BioFire FilmArray Pneumonia Panel enhances detection of pathogens and antimicrobial resistance in lower respiratory tract specimens.Ann Clin Microbiol Antimicrob. 2022 Jun 4;21(1):24. doi: 10.1186/s12941-022-00512-8. Ann Clin Microbiol Antimicrob. 2022. PMID: 35659683 Free PMC article.
-
Respiratory bacterial co-infections in intensive care unit-hospitalized COVID-19 patients: Conventional culture vs BioFire FilmArray pneumonia Plus panel.J Microbiol Methods. 2021 Jul;186:106259. doi: 10.1016/j.mimet.2021.106259. Epub 2021 May 29. J Microbiol Methods. 2021. PMID: 34062210 Free PMC article.
-
Performance evaluation of a PCR panel (FilmArray® Pneumonia Plus) for detection of respiratory bacterial pathogens in respiratory specimens: A systematic review and meta-analysis.Anaesth Crit Care Pain Med. 2023 Dec;42(6):101300. doi: 10.1016/j.accpm.2023.101300. Epub 2023 Sep 12. Anaesth Crit Care Pain Med. 2023. PMID: 37709201 Review.
-
The FilmArray® respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens.Expert Rev Mol Diagn. 2013 Nov;13(8):779-88. doi: 10.1586/14737159.2013.848794. Expert Rev Mol Diagn. 2013. PMID: 24151847 Free PMC article. Review.
Cited by
-
Functional metagenomics highlights varied infection states with dynamics of pathogens and antibiotic resistance in lower respiratory tract infections.Heliyon. 2024 Sep 26;10(19):e38380. doi: 10.1016/j.heliyon.2024.e38380. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39416816 Free PMC article.
-
Evolving strategies in microbe identification-a comprehensive review of biochemical, MALDI-TOF MS and molecular testing methods.J Antimicrob Chemother. 2024 Sep 19;79(Supplement_1):i2-i8. doi: 10.1093/jac/dkae275. J Antimicrob Chemother. 2024. PMID: 39298363 Free PMC article. Review.
-
New methods to detect bacterial or viral infections in patients with chronic obstructive pulmonary disease.Expert Rev Respir Med. 2024 Sep;18(9):693-707. doi: 10.1080/17476348.2024.2396413. Epub 2024 Aug 29. Expert Rev Respir Med. 2024. PMID: 39175157 Review.
-
Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era.Antibiotics (Basel). 2024 Apr 12;13(4):357. doi: 10.3390/antibiotics13040357. Antibiotics (Basel). 2024. PMID: 38667033 Free PMC article. Review.
-
Breaking Boundaries in Pneumonia Diagnostics: Transitioning from Tradition to Molecular Frontiers with Multiplex PCR.Diagnostics (Basel). 2024 Apr 2;14(7):752. doi: 10.3390/diagnostics14070752. Diagnostics (Basel). 2024. PMID: 38611665 Free PMC article. Review.
References
-
- GBD 2015 Disease and Injury Incidence and Prevalence Collaborators . Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388:1545–602. - PMC - PubMed
-
- Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347:465–71. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
